Oxbridge Re Holdings Limited (NASDAQ:OXBR – Get Free Report) was the recipient of a significant growth in short interest during the month of July. As of July 31st, there was short interest totaling 25,578 shares, a growth of 282.5% from the July 15th total of 6,687 shares. Based on an average daily volume of 26,904 shares, the short-interest ratio is currently 1.0 days. Currently, 0.4% of the shares of the company are sold short.
Hedge Funds Weigh In On Oxbridge Re
Several large investors have recently added to or reduced their stakes in OXBR. Virtu Financial LLC purchased a new stake in shares of Oxbridge Re in the third quarter worth $32,000. International Assets Investment Management LLC purchased a new position in shares of Oxbridge Re during the 4th quarter valued at $39,000. Finally, J.W. Cole Advisors Inc. boosted its holdings in Oxbridge Re by 106.1% in the 4th quarter. J.W. Cole Advisors Inc. now owns 68,000 shares of the insurance provider’s stock worth $90,000 after buying an additional 35,000 shares during the period. Hedge funds and other institutional investors own 5.64% of the company’s stock.
Oxbridge Re Stock Performance
OXBR traded up $0.23 during midday trading on Friday, reaching $1.53. The company had a trading volume of 206,609 shares, compared to its average volume of 302,251. The business has a 50-day moving average of $1.26 and a two-hundred day moving average of $1.07. The company has a quick ratio of 8.15, a current ratio of 8.15 and a debt-to-equity ratio of 0.16. Oxbridge Re has a 1 year low of $0.66 and a 1 year high of $2.86. The company has a market cap of $12.39 million, a P/E ratio of -6.12 and a beta of 1.94.
Analysts Set New Price Targets
A number of research firms have commented on OXBR. Weiss Ratings raised shares of Oxbridge Re from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, July 28th. Zacks Research raised Oxbridge Re to a “hold” rating in a report on Wednesday, June 17th. Finally, Maxim Group dropped their price target on Oxbridge Re from $5.00 to $3.00 and set a “buy” rating on the stock in a research note on Tuesday, June 16th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $3.00.
Read Our Latest Research Report on Oxbridge Re
Oxbridge Re Company Profile
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
Featured Stories
- Five stocks we like better than Oxbridge Re
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
- NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
- Sandisk’s Margins Look Like Software. Can They Last?
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
